Free Trial

BiVictriX Therapeutics (BVX) Insider Trading & Ownership

BiVictriX Therapeutics logo

BiVictriX Therapeutics (LON:BVX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
42.56%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
£1,400.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BVX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BiVictriX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BVX Insider Buying and Selling by Quarter

BiVictriX Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/30/2024Robert Edward HawkinsInsiderBuy20,000GBX 7£1,400
(Data available from 1/1/2013 forward)

BVX Insider Trading Activity - Frequently Asked Questions

The list of insiders at BiVictriX Therapeutics includes Iain Gladstone Ross, Robert Edward Hawkins, and Tiffany Jane Thorn. Learn more on insiders at BVX.

42.56% of BiVictriX Therapeutics stock is owned by insiders. Learn more on BVX's insider holdings.

The following insider purchased BVX shares in the last 24 months: Robert Edward Hawkins (£1,400).

Insiders have purchased a total of 20,000 BVX shares in the last 24 months for a total of £1,400 bought.

BiVictriX Therapeutics Key Executives

  • Ms. Tiffany Jane Thorn BSc. MSc. (Age 37)
    M.Sc., CEO & Executive Director
    Compensation: $192.5k
  • Dr. Adrian Howd Ph.D. (Age 53)
    Chief Business Officer & CFO
  • Simon Wallwork
    Secretary


This page (LON:BVX) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners